(Q34568841)

3 August 2017

1 reference

title

Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment (English)

1 reference

von Hippel-Lindau disease

3 August 2017

main subject

1 reference

Taro Shuin

1

1 reference

3 August 2017

Ichiro Yamasaki

2

1 reference

3 August 2017

Kenji Tamura

3

1 reference

3 August 2017

Heiwa Okuda

4

1 reference

3 August 2017

Mutsuo Furihata

5

1 reference

3 August 2017

Shingo Ashida

6

1 reference

3 August 2017

language of work or name

1 reference

1 June 2006

1 reference

Japanese Journal of Clinical Oncology

3 August 2017

published in

1 reference

3 August 2017

volume

36

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

337-343

1 reference

Identification of the von Hippel-Lindau disease tumor suppressor gene

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Molecular basis of the VHL hereditary cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

von Hippel-Lindau disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

Interferon Alfa-2b Three Times Daily and Thalidomide in the Treatment of Metastatic Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYL052

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYL052

1 reference

3 August 2017

1 reference